You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STAT3

Showing 1 - 25 of 1,525
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Refractory Tumor Trial in Dallas, San Antonio (DCR-STAT3)

Recruiting
  • Solid Tumor, Adult
  • Refractory Tumor
  • Dallas, Texas
  • +1 more
Oct 21, 2023

Investigating STAT3 as a Driver of Pathology in Periodontitis

Recruiting
  • Periodontitis
  • no intervention
  • Santiago, Chile
    Faculty of Dentistry, University of Chile
Aug 16, 2022

Genetic Analysis of Immune Disorders

Recruiting
  • DOK 8
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Miami, Florida
      University of Miami
    Jun 27, 2022

    Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Dec 20, 2022

    Novel Genetic Disorders of the Immune System

    Recruiting
    • PI3KCD
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Genetics of Hyperimmunoglobulin E Recurrent Infection Syndrome

      Recruiting
      • Infections
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio

        Recruiting
        • Breast Cancer
        • +7 more
        • Atlanta, Georgia
        • +2 more
        Jun 13, 2022

        Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

        Recruiting
        • Brain Tumor
        • +2 more
        • Atlanta, Georgia
          Children's Healthcare of Atlanta (CHOA)
        Jul 24, 2022

        Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

        Active, not recruiting
        Has Results
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Leukemia
        • Boston, Massachusetts
        • +1 more
        Nov 14, 2022

        Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

        Recruiting
        • Breast Cancer
        • Saint Louis, Missouri
        • +2 more
        Jan 12, 2023

        Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

        Active, not recruiting
        • Advanced Colorectal Carcinoma
        • +24 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 20, 2022

        MDS Trial in Bronx (Pyrimethamine)

        Withdrawn
        • Myelodysplastic Syndromes
        • Bronx, New York
          Montefiore Medical Center
        Sep 15, 2021

        Colorectal Cancer Metastatic Trial in Australia (Nivolumab 10 MG/ML, BNC 105, BBI608)

        Completed
        • Colorectal Cancer Metastatic
        • Nivolumab 10 MG/ML
        • +2 more
        • Albury, New South Wales, Australia
        • +13 more
        Aug 26, 2021

        NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

        Completed
        • NHL
        • +3 more
        • Los Angeles, California
        • +11 more
        Aug 11, 2022

        Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +2 more
        • STAT Inhibitor OPB-111077
        • +3 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Dec 20, 2022

        OCT Reference Database

        Completed
        • Healthy
          • Scottsdale, Arizona
          • +4 more
          Jun 6, 2022

          Coronary Artery Disease Trial in Porto Alegre (Olive oil, Nuts, Control diet)

          Active, not recruiting
          • Coronary Artery Disease
          • Olive oil
          • +2 more
          • Porto Alegre, Rio Grande Do Sul, Brazil
            Instituto de Cardiologia/Fundação Universitária de Cardiologia (
          Sep 8, 2020

          Autosomal-dominant Hyper-IgE Syndrome Trial run by the NIAID (NDV-3A)

          Terminated
          Has Results
          • Autosomal-dominant Hyper-IgE Syndrome
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jun 22, 2020

          Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Gdansk (WP1220)

          Completed
          • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
          • Gdansk, Poland
            Medical University of Gdansk
          Jan 8, 2021

          Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas

          Completed
          • Glioma
            • Montpellier, France
              Uh Montpellier
            Jun 4, 2020

            Application of Regenerative Heart Valves - ESPOIR

            Completed
            • Heart Valve Disease
            • Decellularized human valves
            • Leuven, Belgium
            • +7 more
            Apr 25, 2022

            Rheumatoid Arthritis Trial (Placebo, Nitazoxanide 500Mg Oral Tablet, Escitalopram 10mg)

            Not yet recruiting
            • Rheumatoid Arthritis
            • Placebo
            • +2 more
            • (no location specified)
            Jul 27, 2022

            Pancreas Cancer Trial in Fribourg (Bazedoxifene 20 mg)

            Recruiting
            • Pancreas Cancer
            • Bazedoxifene 20 mg
            • Fribourg, Switzerland
              HFR Fribourg - cantonal hospital
            Feb 9, 2022

            Arthritis, Juvenile Trial in Worldwide (Ustekinumab, Guselkumab)

            Recruiting
            • Arthritis, Juvenile
            • Birmingham, Alabama
            • +50 more
            Jan 31, 2023